H35 Pill: red, oval, 14mm
Generic Name: cedazuridine/decitabine
The pill with imprint H35 (Red, Oval, 14mm) has been identified as Inqovi cedazuridine 100 mg / decitabine 35 mg and is used for Myelodysplastic Syndrome. It belongs to the drug class antineoplastic combinations and is not a controlled substance.
Images for H35
Inqovi
- Generic Name
- cedazuridine/decitabine
- Imprint
- H35
- Strength
- cedazuridine 100 mg / decitabine 35 mg
- Color
- Red
- Size
- 14.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Antineoplastic combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Taiho Oncology, Inc.
- Manufacturer
- Otsuka Pharmaceutical Co., Ltd.
- National Drug Code (NDC)
- 64842-0727
Related images for "H35"
More about Inqovi (cedazuridine / decitabine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antineoplastic combinations
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.